BioCatalystWatch
AUTLWorkspace / AUTL / OverviewCompany library

Autolus Therapeutics plc

Autolus Therapeutics plc (AUTL)

Price
Market cap
Next catalystDec 12, 2026AUTO8 — ALARIC, light-chain amyloidosis · Phase 1 dataCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

AUTO8

BCMA × CD19

PreINDP1P2P3FilingApproved
Upcoming / outlook

CD19

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

CD19

PreINDP1P2P3FilingApproved
Upcoming / outlook

AUTO6NG

GD2

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

AUTO6NG

GD2

PreINDP1P2P3FilingApproved
Upcoming / outlook

AUTO8

BCMA × CD19

PreINDP1P2P3FilingApproved
Upcoming / outlook

CD19

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

CD19

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

AUTO8

BCMA × CD19

PreINDP1P2P3FilingApproved
obe-cel (AUTO1)

CD19

PreINDP1P2P3FilingApproved
obe-cel (AUTO1)

CD19

PreINDP1P2P3FilingApproved
AUTO4

TRBC1

PreINDP1P2P3FilingApproved
AUTO1/22

CD19 × CD22

PreINDP1P2P3FilingApproved
AUTO6NG

GD2

D8 BCMA CAR

BCMA

PreINDP1P2P3FilingApproved

Partner / License out

GD2

PreINDP1P2P3FilingApproved

Approved / commercial

History / paused

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

AUTL PR & News

PR & News

AUTL SEC archive